Harrow Health to Announce Fourth Quarter and Year-End 2021 Financial Results on March 10, 2022

Rhea-AI Summary

Harrow Health (NASDAQ: HROW), an ophthalmic healthcare company, will report its financial results for Q4 and the full year 2021 on March 10, 2022, after market close. A conference call is scheduled for 4:45 p.m. ET the same day to discuss results and provide business updates. Investors can access the Letter to Stockholders on the company's website following the earnings release. Harrow Health focuses on ophthalmic pharmaceuticals through its subsidiaries, ImprimisRx and Visionology.

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2021, on Thursday, March 10, 2022, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update.

Conference Call Details:
Date:	Thursday, March 10, 2022
Time:	4:45 p.m. Eastern time
Participant Dial-in:	1-833-953-2434 (U.S.) 1-412-317-5763 (International)
Replay Dial-in (Passcode 6231870): (telephonic replay through March 17, 2022)	1-877-344-7529 (U.S.) 1-412-317-0088 (International)
Webcast: (online replay through June 10, 2022)	harrowinc.com

About Harrow Health
Harrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare company. The Company owns and operates ImprimisRx, one of the nation’s leading ophthalmology-focused pharmaceutical businesses, and Visionology, a direct-to-consumer eye care subsidiary focused on chronic vision care. Harrow Health also holds non-controlling equity positions in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals, all of which started as Harrow Health subsidiaries, and owns royalty rights in four clinical‑stage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005223/en/

Jamie Webb, Director of Communications and Investor Relations

jwebb@harrowinc.com

615-733-4737

Source: Harrow Health, Inc.

FAQ

When will Harrow Health release its Q4 2021 financial results?

Harrow Health will release its Q4 2021 financial results on March 10, 2022, after market close.

What time is Harrow Health's conference call for Q4 2021 results?

The conference call for Harrow Health's Q4 2021 results is scheduled for 4:45 p.m. Eastern Time on March 10, 2022.

Where can investors find the Letter to Stockholders for Harrow Health?

Investors can find the Letter to Stockholders on Harrow Health's website in the 'Investors' section after the financial results are released.

What companies are part of Harrow Health?

Harrow Health owns ImprimisRx, an ophthalmic-focused pharmaceutical business, and Visionology, which specializes in chronic vision care.